BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31145683)

  • 1. A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer.
    Toivanen R; Furic L
    J Cell Biol; 2019 Jun; 218(6):1771-1772. PubMed ID: 31145683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
    Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
    Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.
    Nowak DG; Katsenelson KC; Watrud KE; Chen M; Mathew G; D'Andrea VD; Lee MF; Swamynathan MM; Casanova-Salas I; Jibilian MC; Buckholtz CL; Ambrico AJ; Pan CH; Wilkinson JE; Newton AC; Trotman LC
    J Cell Biol; 2019 Jun; 218(6):1943-1957. PubMed ID: 31092557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression.
    Chen M; Pratt CP; Zeeman ME; Schultz N; Taylor BS; O'Neill A; Castillo-Martin M; Nowak DG; Naguib A; Grace DM; Murn J; Navin N; Atwal GS; Sander C; Gerald WL; Cordon-Cardo C; Newton AC; Carver BS; Trotman LC
    Cancer Cell; 2011 Aug; 20(2):173-86. PubMed ID: 21840483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.
    Nilchian A; Johansson J; Ghalali A; Asanin ST; Santiago A; Rosencrantz O; Sollerbrant K; Vincent CT; Sund M; Stenius U; Fuxe J
    Cancer Res; 2019 Jan; 79(1):47-60. PubMed ID: 30385615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer.
    Kim RJ; Bae E; Hong YK; Hong JY; Kim NK; Ahn HJ; Oh JJ; Park DS
    Oncology; 2014; 87(5):270-9. PubMed ID: 25139413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
    Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
    Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
    Narayanan NK; Nargi D; Randolph C; Narayanan BA
    Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of the FKBP51-PHLPP2-AKT signaling complex in cerebral ischemia/reperfusion injury in rats.
    Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
    Brain Res; 2014 May; 1566():60-8. PubMed ID: 24746496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gata3 antagonizes cancer progression in Pten-deficient prostates.
    Nguyen AH; Tremblay M; Haigh K; Koumakpayi IH; Paquet M; Pandolfi PP; Mes-Masson AM; Saad F; Haigh JJ; Bouchard M
    Hum Mol Genet; 2013 Jun; 22(12):2400-10. PubMed ID: 23428429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers.
    Labbé DP; Uetani N; Vinette V; Lessard L; Aubry I; Migon E; Sirois J; Haigh JJ; Bégin LR; Trotman LC; Paquet M; Tremblay ML
    Cancer Res; 2016 Jun; 76(11):3130-5. PubMed ID: 27020859
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Parisotto M; Grelet E; El Bizri R; Dai Y; Terzic J; Eckert D; Gargowitsch L; Bornert JM; Metzger D
    J Exp Med; 2018 Jun; 215(6):1749-1763. PubMed ID: 29743291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
    Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
    Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death.
    Saxena S; Shukla S; Kakkar P
    Toxicol Appl Pharmacol; 2018 May; 347():92-103. PubMed ID: 29626488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
    Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.